Home Cart 0 Sign in  

[ CAS No. 34079-31-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 34079-31-7
Chemical Structure| 34079-31-7
Structure of 34079-31-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 34079-31-7 ]

Related Doc. of [ 34079-31-7 ]

Alternatived Products of [ 34079-31-7 ]

Product Details of [ 34079-31-7 ]

CAS No. :34079-31-7 MDL No. :MFCD00020830
Formula : C13H16N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :ZCGHEBMEQXMRQL-NSHDSACASA-N
M.W : 248.28 Pubchem ID :6950961
Synonyms :
Chemical Name :Benzyl (S)-2-carbamoylpyrrolidine-1-carboxylate

Calculated chemistry of [ 34079-31-7 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.38
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 69.53
TPSA : 72.63 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.83
Log Po/w (XLOGP3) : 0.56
Log Po/w (WLOGP) : 0.74
Log Po/w (MLOGP) : 0.9
Log Po/w (SILICOS-IT) : 0.79
Consensus Log Po/w : 0.96

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.65
Solubility : 5.57 mg/ml ; 0.0224 mol/l
Class : Very soluble
Log S (Ali) : -1.66
Solubility : 5.46 mg/ml ; 0.022 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.3
Solubility : 1.24 mg/ml ; 0.00499 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.6

Safety of [ 34079-31-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 34079-31-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 34079-31-7 ]
  • Downstream synthetic route of [ 34079-31-7 ]

[ 34079-31-7 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 1148-11-4 ]
  • [ 34079-31-7 ]
YieldReaction ConditionsOperation in experiment
49% With pyridine; di-<i>tert</i>-butyl dicarbonate; ammonium bicarbonate In 1,4-dioxane at 20℃; To a solution of starting 1-[(phenylmethyl)oxy]carbonyl}-L-proline (8.0 g, 32.09 mmol), pyridine (1.5 mL), (BoC)2O (9.1 g, 41.72 mmol) in 1 ,4-dioxane (40 ml_) at rt was added ammonium hydrogen carbonate (3.2 g, 40.43 mmol). After stirring at room temperature overnight, the reaction mixture was treated with EtOAc (100 mL), and then the mixture was washed with water (50 mL), followed by 5percent H2SO4- The organic layer was collected, dried(Na2SO4), filtered. The volatiles were removed by evaporation in vacuo. The resulting clear oil was triturated with ether. The precipitates were filtered and further dried under vacuum to yield the title compound as a white solid (3.9 g, 49percent). MH+ 249.
13.5 g
Stage #1: With chloroformic acid ethyl ester; triethylamine In tetrahydrofuran at -5℃; for 0.333333 h;
Stage #2: With ammonium hydroxide In tetrahydrofuran at -5 - 20℃; for 18 h;
Step A - Syntheses of Intermediate Compound Int-13b (0313) (0314) Ethyl chloroformate (12 mL, 125 mmol) in 180 mL of THF was added drop-wise to a cooled solution (-5°C) of compound Z-Pro-OH (13.8 g, 55.5 mmol), TEA (7.71 mL, 55.5 mmol). The resulting slurry was allowed to stir for 20 minutes at -5°C before saturated NH4OH (15 mL) was added. The solution was allowed to stir at room temperature for 18 hours, volatiles were removed, and the resulting residue was taken up in EtOAc (180 mL). The undissolved white precipitate was filtered off and rinsed with EtOAc (100 mL). The organic layers were dried over Na2SO4 and concentrated in vacuo to provide the desired product (13.5 g) as off-white amorphous solid (Int-13b). MS (ESI) m/e (M+H+): 249
Reference: [1] Organic and Biomolecular Chemistry, 2005, vol. 3, # 1, p. 84 - 96
[2] Synlett, 2004, # 3, p. 558 - 560
[3] Patent: WO2005/121135, 2005, A1, . Location in patent: Page/Page column 240-241
[4] Canadian Journal of Chemistry, 2007, vol. 85, # 2, p. 85 - 95
[5] Journal of the American Chemical Society, 2018, vol. 140, # 5, p. 1627 - 1631
[6] Tetrahedron Asymmetry, 2004, vol. 15, # 12, p. 1831 - 1834
[7] European Journal of Organic Chemistry, 2005, # 20, p. 4287 - 4295
[8] Synlett, 2006, # 6, p. 889 - 892
[9] Chemische Berichte, 1983, vol. 116, # 5, p. 2037 - 2040
[10] Organic Syntheses, 2008, vol. 85, p. 72 - 87
[11] Carbohydrate Research, 2013, vol. 381, p. 12 - 18
[12] Pharmazie, 1992, vol. 47, # 9, p. 710 - 711
[13] Organic and Biomolecular Chemistry, 2011, vol. 9, # 1, p. 265 - 272
[14] Organic and Biomolecular Chemistry, 2017, vol. 15, # 34, p. 7196 - 7203
[15] Patent: WO2007/67904, 2007, A2, . Location in patent: Page/Page column 14; 24
[16] Journal of Pharmaceutical Sciences, 1991, vol. 80, # 9, p. 837 - 842
[17] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 3, p. 591 - 600
[18] Tetrahedron, 1996, vol. 52, # 10, p. 3521 - 3546
[19] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 24, p. 6568 - 6572
[20] Journal of Organic Chemistry, 2009, vol. 74, # 15, p. 5260 - 5266
[21] Patent: WO2010/111483, 2010, A1, . Location in patent: Page/Page column 115-116
[22] Patent: WO2010/138791, 2010, A1, . Location in patent: Page/Page column 94-95
[23] Tetrahedron Letters, 2012, vol. 53, # 29, p. 3777 - 3779
[24] Tetrahedron Letters, 2012, vol. 53, # 28, p. 3672 - 3675
[25] Tetrahedron Letters, 2013, vol. 54, # 36, p. 4975 - 4977
[26] Tetrahedron Letters, 2014, vol. 55, # 50, p. 6831 - 6835
[27] Patent: EP2545060, 2015, B1, . Location in patent: Paragraph 0313; 0314
[28] Patent: WO2007/77186, 2007, A1,
  • 2
  • [ 61350-60-5 ]
  • [ 34079-31-7 ]
YieldReaction ConditionsOperation in experiment
82% With ammonia In dichloromethane at 0 - 20℃; Large scale The obtained N-benzyloxycarbonyl-L-prolyl chloride was stirred under cooling to 0 ~ 10 ° C, the temperature was controlled to 10 ~ 20 ° C, and ammonia gas was passed for 12 hours. After completion of the reaction, the resulting mixture was concentrated to dryness under reduced pressure. 100 kg dichloromethane was added, stirred to dissolve, cooled to 0 ~ 5 ° C, the temperature was controlled to 10 ~ 15 ° C, 30percent sodium hydroxide was added to adjust pH to 12 ~ 13, stirred at 10 ~ 15 ° C for 1 hour. pH was retested, the mixture was allowed to stand, liquid separation was carried out, aqueous layer was separated, 10 kg activated carbon was added to dichloromethane layer, stirred at 20-25° C for 40 minutes, filtered, and the resulting dichloromethane solution was washed twice with 200 kg of purified water, 30 kg anhydrous magnesium sulfate was added to dichloromethane layer, dehydrated, filtered, dichloromethane was distilled off, cooled to 5 ~ 10 ° C, 500 kg petroleum ether was added, solids were precipitated, stirred at 5 ~ 10 ° C for 8 hours, filtered, washed with 50 kg petroleum ether and dried to get 177 kg white solid. Yield 82.0percent, purity 99.8percent, optical purity of 99.9percent (HPLC area normalization method)
Reference: [1] Patent: CN104086475, 2016, B, . Location in patent: Paragraph 0026
[2] Patent: WO2007/77186, 2007, A1, . Location in patent: Page/Page column 32
  • 3
  • [ 3304-59-4 ]
  • [ 34079-31-7 ]
Reference: [1] European Journal of Medicinal Chemistry, 2009, vol. 44, # 7, p. 2807 - 2814
  • 4
  • [ 147-85-3 ]
  • [ 34079-31-7 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 20, p. 4287 - 4295
[2] Tetrahedron Asymmetry, 2004, vol. 15, # 12, p. 1831 - 1834
[3] Journal of Pharmaceutical Sciences, 1991, vol. 80, # 9, p. 837 - 842
[4] Carbohydrate Research, 2013, vol. 381, p. 12 - 18
[5] Patent: CN104086475, 2016, B,
  • 5
  • [ 501-53-1 ]
  • [ 34079-31-7 ]
Reference: [1] Journal of Pharmaceutical Sciences, 1991, vol. 80, # 9, p. 837 - 842
[2] Carbohydrate Research, 2013, vol. 381, p. 12 - 18
[3] Patent: CN104086475, 2016, B,
  • 6
  • [ 124980-30-9 ]
  • [ 34079-31-7 ]
Reference: [1] European Journal of Organic Chemistry, 2009, # 6, p. 904 - 911
  • 7
  • [ 60433-33-2 ]
  • [ 34079-31-7 ]
Reference: [1] Organic and Biomolecular Chemistry, 2011, vol. 9, # 1, p. 265 - 272
  • 8
  • [ 14030-00-3 ]
  • [ 34079-31-7 ]
Reference: [1] Helvetica Chimica Acta, 1989, vol. 72, p. 401 - 425
  • 9
  • [ 14030-00-3 ]
  • [ 34079-31-7 ]
Reference: [1] Helvetica Chimica Acta, 1989, vol. 72, p. 401 - 425
  • 10
  • [ 501-53-1 ]
  • [ 7531-52-4 ]
  • [ 34079-31-7 ]
Reference: [1] Journal of Biological Chemistry, 1951, vol. 193, p. 81,87
  • 11
  • [ 2766-18-9 ]
  • [ 34079-31-7 ]
Reference: [1] Helvetica Chimica Acta, 1989, vol. 72, p. 401 - 425
  • 12
  • [ 34079-31-7 ]
  • [ 119020-03-0 ]
YieldReaction ConditionsOperation in experiment
74%
Stage #1: With borane In tetrahydrofuran at 0℃; for 7 h; Heating / reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran at 0℃; for 6 h; Heating / reflux
Stage #3: With sodium hydroxide In tetrahydrofuran; water
A typical procedure for the reduction is as follows: starting with a solution of (S)-2-carbamoyl-l-7V-CBz-pyrrolidine (0.5g, 2mmol) in THF (10ml), borane BH3 (12ml, 12mmol, 1 .OM THF solution) was added slowly at 0°C under N2. The resulting solution was heated to reflux for 7 hours, then cooled to 0°C, followed by slow addition of 4.5mL of 12N HC1 to destroy the B-N complex. The mixture was heated to reflux for 6 hours, cooled to roomed temperature (RT), then was neutralized to ph8 by a WNaOH aqueous solution. After THF and water were removed under reduced pressure, the crude product was purified by use offlash silica gel column chromatography (1/10 = MeOH/CHzC^) to afford a clear, slightlyyellow oil in 74percent yield (348mg).
Reference: [1] Chemistry - A European Journal, 2006, vol. 12, # 16, p. 4321 - 4332
[2] Patent: WO2006/7586, 2006, A1, . Location in patent: Page/Page column 31-32
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 34079-31-7 ]

Amino Acid Derivatives

Chemical Structure| 4801-79-0

[ 4801-79-0 ]

(S)-Benzyl (1-amino-4-methyl-1-oxopentan-2-yl)carbamate

Similarity: 0.90

Chemical Structure| 86161-49-1

[ 86161-49-1 ]

(2S,3S)-Benzyl (1-amino-3-methyl-1-oxopentan-2-yl)carbamate

Similarity: 0.89

Chemical Structure| 5241-56-5

[ 5241-56-5 ]

(R)-Benzyl (1-amino-1-oxo-3-phenylpropan-2-yl)carbamate

Similarity: 0.89

Chemical Structure| 13139-28-1

[ 13139-28-1 ]

(S)-Benzyl (1-amino-3-methyl-1-oxobutan-2-yl)carbamate

Similarity: 0.87

Chemical Structure| 58117-53-6

[ 58117-53-6 ]

H-Lys(Z)-NH2.HCl

Similarity: 0.86